RITE AID PIVOTS FROM A TURNAROUND STORY TO A GROWTH STORY $RAD $CVS $WAG
This post was just published on ZYX Buy Change Alert. RAD is long from an average of $4.96 and 60% of the full core position size is being held. As of this writing in the after hours RAD is trading at $8.11. Partial profits have been taken as high as $7.38. RAD and Envision Pharmaceutical Services have entered into a definitive agreement under which RAD will buy EnvisionRx for $2B. EnvisionRx is a Prescription Benefit Management Company. RAD is following in the footsteps of CVS. The transaction is expected to be accretive to RAD’s earnings per share in the first full year. Until